The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter
Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
A one-shot gene-editing cholesterol therapy could soon be a reality
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
